OptoRhythm is pioneering a novel, light-based approach to heart rhythm management.
Founded on over 20 years of groundbreaking research by Prof. Lior Gepstein (CSO & Co-Founder), a global leader in cardiac electrophysiology and optogenetics, OptoRhythm is transforming Atrial Fibrillation (AF) treatment. Our technology combines optogenetic gene therapy with an implantable micro-LED array to create the world’s first Optic Defibrillator. Unlike traditional electric shock methods, OptoRhythm’s Optic Defibrillator painlessly stops chaotic atrial contractions using precise light pulses. This real-time, repeatable, non-destructive solution addresses current AF treatment limitations and will provide long-term rhythm control as well as improved patient’s outcomes and reduced AF burden.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Wadi El-Haj 13, Nazareth,israel
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Keywords
- Banxo.
- HQ
- Nazareth
Optorhythm Ltd Questions
Optorhythm Ltd's website is https://ngt-healthcare2.com/optorhythm/
Optorhythm Ltd's LinkedIn profile is https://il.linkedin.com/company/optorhythm-ltd
Optorhythm Ltd has
2 employees.
View email and phone details for 2
employees at Optorhythm Ltd.
Optorhythm Ltd's industry is
Medical Equipment Manufacturing
Optorhythm Ltd's top competitors are
Eusense,
Cardea Sciences,
Peled Strategic Consulting,
Banxo,
Ngt,
Deepsolutions,
Ray Imaging Solutions,
Fe-Free,
Shoni Health Ventures,
Clarytix.
Optorhythm Ltd's categories are Medical Equipment Manufacturing
Optorhythm Ltd's founding year is 2024
